WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders
T

Panel Discussion Chaired by Dr. Weichart on Big Data and How to Move the Field Towards Precision Medicine in ILDs: Session 7

By WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders FEATURING Thomas Weichhart
By WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders FEATURING Thomas Weichhart
46 views
July 24, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

28:46
Boehringer Ingelheim

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Featured Video

39:42
Boehringer Ingelheim

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

Related Content

AUTOPLAY
51:53
Shaheen Islam

ATS 2022: Approach to Lung Nodules in 2022

16:13
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Post COVID-19 Lung Complications

Feat. M. Padilla
53:31
CHEST 2022 Coverage

Approaching Sarcoidosis Therapy From a 21st Century Perspective

Feat. D. Culver
19:21
CHEST 2022 Coverage

A Radiologist's Approach to Subsolid Pulmonary Nodules

Feat. A. Guttentag
36:52
Cleveland Clinic Respiratory Institute

Transbronchial Cryobiopsy for Diagnostic Bronchoscopy

Feat. B. Benn
28:18
UCLA Health

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

Feat. J. Belperio
52:53
University of Colorado Department of Medicine

Interstitial Lung Disease in Rheumatic Diseases

Feat. M. Griffith
24:02
CHEST 2022 Coverage

Bronchoscopic Imaging for Interstitial Lung Disease

Feat. G. Zhi Cheng
18:52
WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

Defining the Molecular Natural History of Early and Progressive Pulm…

Feat. N. Banovich
25:48
University of Colorado Department of Medicine

Sarcoidosis: Diagnosis and Management

Feat. N. Held
21:34
CHEST 2022 Coverage

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Feat. T. Kulkarni
16:51
WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

Challenges in ILD: Prediction With or Without Big Data

Feat. T. Fingerlin
14:58
WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

Auto-Antibodies in IPF

Feat. T. Plante-Bordeneuve
09:19
Toby Maher

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

14:39
WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

Beyond Treatment Preventing Progressive Pulmonary Fibrosis

Feat. J. Kropski
34:08
Keck School of Medicine of USC

Medical Marijuana in Rheumatology: Fact or Fiction?

Feat. A. Wells
27:38
Temple Lung Center

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Feat. R. Gupta
12:52
The France Foundation

Identifying the Signs and Symptoms of Progressive Pulmonary Fibrosis

Feat. V. Khangoora
16:54
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Lymphangioleiomyomatosis: A Clinical Overview

Feat. F. Mccormack
40:52
RheumNow

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

Feat. J. Sparks, J. Cush